生存分析からみた進行肝細胞癌に対するソラフェニブ投与例の検討
スポンサーリンク
概要
- 論文の詳細を見る
We investigated the pretreatment factors that were associated with the outcome of patients with hepatocellular carcinoma (HCC) who received the administration of sorafenib. Survival rates were compared according to the initial treatment for HCC, Child-Pugh class, extrahepatic metastasis, portal vein invasion, AFP, AFP-L3, and PIVKA-II, in 26 HCC patients who were administered sorafenib. Univariate analysis revealed the state of portal vein invasion (≤Vp2 vs. ≥Vp3) as a factor that was associated patient survival (p=0.016). By multivariate analysis, the state of portal vein invasion (hazard ratio, 4.631; 95% confidence interval, 1.541-13.921; p=0.006) was selected as factors that affected patient survival. The present result shows that portal vein invasion of ≥Vp3 indicated poor outcome in patients with HCC treated by sorafenib.
論文 | ランダム
- 手術創傷に対する眼組織の反応
- IEICE Transactions on Communications, Status Report
- 米国におけるコンピュ-タシステム及びソフトウェアの開発・販売に関する著作権法及び特許法の考察
- Induction of Xanthine Dehydrogenase by TCDD(PROCEEDINGS OF 24TH SYMPOSIUM ON TOXICOLOGY AND ENVIRONMENTAL HEALTH)
- Examination of the Dorsal Lingual Surface of the Crab-eating Monkey Macaca irus by Scanning Electron Microscope